Home›People›Drew Dennison
DD

Drew Dennison

Director at SimpleRose. Also a director at Allotera and AI Proteins.

DirectorRoles at 3 startups
Updated Nov 10, 2026·Latest SEC filing Jul 23, 2026·Suggest an edit

About Drew Dennison

Form D filings for SimpleRose in 2023 list Drew Dennison as director.

Form D filings also name Drew Dennison as a director at Allotera and AI Proteins.

Drew Dennison first appears on SEC filings in 2021.

Experience

This experience comes from Drew Dennison's profile and from SEC filings. For roles taken from filings, the years are when the filings name Drew Dennison in the role, so the role may have started earlier or lasted longer.

SimpleRose Inc. Current
Director
2020 – Present · St. Louis, MO
Wugen Current
Board Member
2020 – Present
Geneoscopy Current
Board Member
2019 – Present
Lightchain Capital LLC Current
Managing Director
2018 – Present
CareVet Current
Board Member
2018 – Present
Allotera Therapeutics, Inc.
Director
2021 – 2026 · St. Louis, MO
Develops donor-cell therapies for people with blood cancers.
AI Proteins, Inc.
Chief Executive Officer, Board Member
2022 – 2024 · Boston, MA
NextRNA Therapeutics
Board Member
2021 – 2022
TD Ameritrade
Integration Co-Lead and Executive Sponsor
2016 – 2018
Scottrade
Chief Operating Officer
2008 – 2017
Wachovia Corp
Vice President, Accounting Director
2007 – 2008
A.G. Edwards & Sons, Inc.
Controller, Vice President
2005 – 2007
Deloitte
Manager, Audit and Assurance
1999 – 2005

Key Colleagues at Startups

The people Drew Dennison works with at each company, as listed on that company's latest Form D.

Allotera Therapeutics, Inc. · Form D/A, Jul 23, 2026
KL
Kevin Li
Director
NM
ND
Kumar Srinivasan
Kumar Srinivasan
President & Chief Executive Officer, director
Matthew Cooper
Matthew Cooper
Co-Founder & Chief Scientific Officer
BH
Bosun Hau
Director
Cherry Thomas
Cherry Thomas
Chief Medical Officer
Ayman Kabakibi
Ayman Kabakibi
Chief Operating Officer & EVP, R&D
BM
AI Proteins, Inc. · Form D, Apr 4, 2024
BS
JN
Julia Novina
Chief Legal Officer
CB
Chris Bahl
Executive officer and director
BE
Bruce Evans
Director
WD
Wendy Dwyer
Executive officer
TK
NB
Noah Beerman
Executive officer and director
MS
SimpleRose Inc. · Form D, Apr 6, 2023
CL
Carl Ledbetter
Executive officer and director
BM
MM
Matt Mosman
Director

Sources

  1. SECAllotera Therapeutics, Inc. Form D/A, filed Jul 23, 2026
  2. SECAI Proteins, Inc. Form D, filed Apr 4, 2024
  3. SECSimpleRose Inc. Form D, filed Apr 6, 2023